Advertisement

Topics

Adnexus Therapeutics, Inc Company Profile

14:43 EDT 25th September 2018 | BioPortfolio

Adnexus Therapeutics, Inc. (formerly Compound Therapeutics, Inc.) is focused on generating vital medicines through the discovery, development, and commercialization of our broadly applicable new therapeutic class, AdNectins™.
AdNectins have the potential to become a dominant class of protein therapeutics, overcoming the limitations of current protein classes, including antibodies and soluble receptors. AdNectins are designed and optimized using PROfusion™, Adnexus' proprietary protein design technology that uniquely enables selection of molecules with ideal product characteristics. Together, AdNectins and PROfusion are a powerful combination that enables the design and production of product candidates with desired drug properties for a wide variety of targets and therapeutic areas.

Adnexus is developing a portfolio of AdNectin therapeutic products. Angiocept™ (CT-322), an AdNectin that inhibits the activation of human vascular endothelial growth factor receptor 2 (VEGFR-2), is Adnexus' first product that was designed using this proprietary approach. Angiocept (CT-322) is scheduled to begin Phase I clinical studies in oncology in 2006.

Adnexus Therapeutics is led by a management team and Board of Directors with extensive industry experience covering all aspects of building successful biopharmaceutical companies. Collectively, the team has developed and launched over 20 marketed biologic products. The Company is backed by four leading venture firms: Atlas Venture, Flagship Ventures, Polaris Venture Partners, and Venrock Associates.

Location

100 Beaver Street
Waltham
Massachusetts
02453
United States of America

Contact

Phone: (781) 891-3745
Fax: (781) 891-3796
Email: info@adnexustx.com


News Articles [725 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb: Business Development in a Global Community

In this exclusive interview, Fintan Walton talks to Graham Brazier, Vice President and Head of Business Development at Bristol-Myers Squibb (BMS), about the world of big pharma business development an...

Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions

About Proteostasis Therapeutics, Inc. Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other di...

Technical Perspectives on Biotech Stocks -- Adaptimmune Therapeutics, Akebia Therapeutics, ...

www.wallstequities.com/registration Adaptimmune Therapeutics Shares in Abingdon, the UK headquartered Adaptimmune Therapeutics PLC rose slightly by 0.41%, ending Wednesday's trading session at $12...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

Anika Therapeutics (ANIK) versus Onconova Therapeutics (ONTX) Financial Survey

Anika Therapeutics and Onconova Therapeutics are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earn...

Q Therapeutics, ReproCELL form MAGiQ, a CNS diseases JV

Fellow cell therapy companies Q Therapeutics Inc. and ReproCELL Inc. formed a 50/50-owned CNS disease-focused joint venture, which will be headquartered in Japan and known as MAGiQ Therapeutics Inc. R...

Small-Cap Snapshot: Galectin Therapeutics flies after receiving a patent for treating pulmonary fibrosis

Aquinox Pharmaceuticals, Summit Therapeutics and Global Blood Therapeutics are also making news

Deals and M&As this week: Pliant Therapeutics, MolMed, Modus Therapeutics

Pliant Therapeutics has raised $62m through a series B financing round from Cowen Healthcare Investments. The funding round also included participation...Read More... The post Deals and M&As thi...

PubMed Articles [434 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Clinical Trials [154 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1256 Associated Companies listed on BioPortfolio]

Adnexus Therapeutics, Inc.

Adnexus Therapeutics, Inc. (formerly Compound Therapeutics, Inc.) is focused on generating vital medicines through the discovery, development, and commercialization of our broadly applicable new thera...

Adnexus Therapeutics, Inc

Adnexus Therapeutics, Inc. (formerly Compound Therapeutics, Inc.) is focused on generating vital medicines through the discovery, development, and commercialization of our broadly applicable new thera...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Adnexus Therapeutics, Inc" on BioPortfolio

We have published hundreds of Adnexus Therapeutics, Inc news stories on BioPortfolio along with dozens of Adnexus Therapeutics, Inc Clinical Trials and PubMed Articles about Adnexus Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adnexus Therapeutics, Inc Companies in our database. You can also find out about relevant Adnexus Therapeutics, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record